This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2010 Mar 15;181(6):539-44.

doi: 10.1164/rccm.200912-1943UP.

Update in cystic fibrosis 2009

Peter J Mogayzel Jr¹, Patrick A Flume

Affiliations

PMID: 20208039
DOI: 10.1164/rccm.200912-1943UP

Review

Update in cystic fibrosis 2009

Peter J Mogayzel Jr et al. Am J Respir Crit Care Med. 2010.

. 2010 Mar 15;181(6):539-44.

doi: 10.1164/rccm.200912-1943UP.

Authors

Peter J Mogayzel Jr¹, Patrick A Flume

Affiliation

¹ Department of Pediatrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. pmogayze@jhmi.edu

PMID: 20208039
DOI: 10.1164/rccm.200912-1943UP

No abstract available

PubMed Disclaimer

Comment in

Ceramide and cystic fibrosis lung disease.
Brodlie M, Lordan JL, Ward C. Brodlie M, et al. Am J Respir Crit Care Med. 2011 Jan 1;183(1):133. doi: 10.1164/ajrccm.183.1.133. Am J Respir Crit Care Med. 2011. PMID: 21193790 No abstract available.

Similar articles

Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Assael BM. Assael BM. Expert Rev Anti Infect Ther. 2011 Nov;9(11):967-73. doi: 10.1586/eri.11.131. Expert Rev Anti Infect Ther. 2011. PMID: 22029514 Review.
Inhaled aztreonam.
O'Sullivan BP, Yasothan U, Kirkpatrick P. O'Sullivan BP, et al. Nat Rev Drug Discov. 2010 May;9(5):357-8. doi: 10.1038/nrd3170. Nat Rev Drug Discov. 2010. PMID: 20431562
Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).
Oermann CM, McCoy KS, Retsch-Bogart GZ, Gibson RL, McKevitt M, Montgomery AB. Oermann CM, et al. J Antimicrob Chemother. 2011 Oct;66(10):2398-404. doi: 10.1093/jac/dkr303. Epub 2011 Jul 22. J Antimicrob Chemother. 2011. PMID: 21784781 Clinical Trial.
Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
Manno G, Cruciani M, Romano L, Scapolan S, Mentasti M, Lorini R, Minicucci L. Manno G, et al. Int J Antimicrob Agents. 2005 Mar;25(3):193-7. doi: 10.1016/j.ijantimicag.2004.11.009. Int J Antimicrob Agents. 2005. PMID: 15737511
Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
Hata JS, Fick RB Jr. Hata JS, et al. Clin Chest Med. 1988 Dec;9(4):679-89. Clin Chest Med. 1988. PMID: 3148384 Review.

See all similar articles

Cited by

Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin.
Rada B, Gardina P, Myers TG, Leto TL. Rada B, et al. Mucosal Immunol. 2011 Mar;4(2):158-71. doi: 10.1038/mi.2010.62. Epub 2010 Oct 20. Mucosal Immunol. 2011. PMID: 20962773 Free PMC article.
Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing.
Descamps D, Le Gars M, Balloy V, Barbier D, Maschalidi S, Tohme M, Chignard M, Ramphal R, Manoury B, Sallenave JM. Descamps D, et al. Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1619-24. doi: 10.1073/pnas.1108464109. Epub 2012 Jan 17. Proc Natl Acad Sci U S A. 2012. PMID: 22307620 Free PMC article.
Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repair.
Itokazu Y, Pagano RE, Schroeder AS, O'Grady SM, Limper AH, Marks DL. Itokazu Y, et al. Am J Physiol Cell Physiol. 2014 May 1;306(9):C819-30. doi: 10.1152/ajpcell.00168.2013. Epub 2014 Feb 5. Am J Physiol Cell Physiol. 2014. PMID: 24500283 Free PMC article.
Augmentation of CFTR maturation by S-nitrosoglutathione reductase.
Zaman K, Sawczak V, Zaidi A, Butler M, Bennett D, Getsy P, Zeinomar M, Greenberg Z, Forbes M, Rehman S, Jyothikumar V, DeRonde K, Sattar A, Smith L, Corey D, Straub A, Sun F, Palmer L, Periasamy A, Randell S, Kelley TJ, Lewis SJ, Gaston B. Zaman K, et al. Am J Physiol Lung Cell Mol Physiol. 2016 Feb 1;310(3):L263-70. doi: 10.1152/ajplung.00269.2014. Epub 2015 Dec 4. Am J Physiol Lung Cell Mol Physiol. 2016. PMID: 26637637 Free PMC article.
Update in Cystic Fibrosis 2018.
Ramsey BW, Downey GP, Goss CH. Ramsey BW, et al. Am J Respir Crit Care Med. 2019 May 15;199(10):1188-1194. doi: 10.1164/rccm.201902-0310UP. Am J Respir Crit Care Med. 2019. PMID: 30917288 Free PMC article. Review. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- Genetic Alliance
- MedlinePlus Health Information